Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarity PAGE 30 (2022) Abstr 10136 Svensson RJ, Ooi QX, Friberg LE, Lopez Lazaro L, Hansson E. ConferenceOncologyPharmacometrics Pharmetheus Affiliates Senior Consultant Qing Xi Ooi See bio Scientific Advisor Lena Friberg See bio Senior Consultant, Regulatory Affairs Emma Hansson See bio Quality Control and Medical Writer Viviana Moroso See bio
